jan 1, 2006 - NCI's Study of Tamoxifen
and Raloxifene (STAR)
Description:
Results of NCI's Study of Tamoxifen and Raloxifene (STAR) show that postmenopausal women at increased risk of breast cancer can reduce their risk of developing the disease if they take the antiestrogen drug raloxifene. The risk of serious side effects is lower with raloxifene than with tamoxifen.
Added to timeline:
Date: